论文部分内容阅读
目的探讨缬沙坦治疗扩张型心肌病的临床疗效。方法回顾分析40例患者的临床资料。结果观察组20例中,显效13例,有效5例,无效2例,总有效率为84;对照组20例中,显效9例,有效4例,无效7例,总有效率为66。两组总有效率比较,有统计学差异(P<0.05)。结论缬沙坦治疗扩张型心肌病心力衰竭可以显著改善心脏重构,提高患者的生活质量,降低其再住院率,临床疗效确切且安全可靠,值得临床应用。
Objective To investigate the clinical efficacy of valsartan in the treatment of dilated cardiomyopathy. Methods The clinical data of 40 patients were retrospectively analyzed. Results In the observation group of 20 cases, 13 cases were markedly effective, 5 cases were effective, 2 cases were ineffective, and the total effective rate was 84. Among the 20 cases in the control group, 9 cases were markedly effective, 4 cases were effective, 7 were ineffective and the total effective rate was 66. The total effective rate was statistically significant (P <0.05). Conclusion Valsartan treatment of dilated cardiomyopathy heart failure can significantly improve cardiac remodeling, improve the quality of life of patients, reduce their rehospitalization rate, the exact clinical efficacy and safety, it is worth clinical application.